{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:56:51Z","timestamp":1790863011911,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59552-1","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:08:19Z","timestamp":1782994099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between polycystic kidney disease and valve disease: a nationwide population-based nested case-control study"],"prefix":"10.1038","volume":"16","author":[{"given":"Pi-Ching","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-lp","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Jei","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing\u2011Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hsiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Huei","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Chien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"Suppl 2S","key":"59552_CR1","first-page":"S1","volume":"107","author":"VE Torres","year":"2025","unstructured":"Torres, V. E. et al. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney Int. 107 (Suppl 2S), S1\u2013S239 (2025).","journal-title":"Kidney Int."},{"issue":"9569","key":"59552_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., Harris, P. C. & Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 369 (9569), 1287\u20131301 (2007).","journal-title":"Lancet"},{"key":"59552_CR3","doi-asserted-by":"crossref","unstructured":"Sagar, P. S. et al. Cardiovascular manifestations and management in ADPKD. Kidney Med. (2023).","DOI":"10.1016\/j.ekir.2023.07.017"},{"issue":"4","key":"59552_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrneph.2009.13","volume":"5","author":"T Ecder","year":"2009","unstructured":"Ecder, T. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat. Rev. Nephrol. 5 (4), 221\u2013228 (2009).","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"59552_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ekir.2019.12.007","volume":"5","author":"IY Kuo","year":"2020","unstructured":"Kuo, I. Y. & Chapman, A. B. Polycystins, ADPKD, and cardiovascular disease. Kidney Int. Rep. 5 (4), 396\u2013406 (2020).","journal-title":"Kidney Int. Rep."},{"issue":"5\u20136","key":"59552_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1242\/dmm.003194","volume":"3","author":"S Mangos","year":"2010","unstructured":"Mangos, S. et al. The ADPKD genes pkd1a\/b and pkd2 regulate extracellular matrix formation. Dis. Model. Mech. 3 (5\u20136), 354\u2013365 (2010).","journal-title":"Dis. Model. Mech."},{"issue":"10","key":"59552_CR7","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bbadis.2011.03.003","volume":"1812","author":"IA Drummond","year":"2011","unstructured":"Drummond, I. A. Polycystins, focal adhesions and extracellular matrix interactions. Biochim. Biophys. Acta. 1812 (10), 1322\u20131328 (2011).","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"59552_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1053\/ajkd.2001.29216","volume":"38","author":"A Lumiaho","year":"2001","unstructured":"Lumiaho, A. et al. Mitral valves prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am. J. Kidney Dis. 38 (6), 1208\u20131216 (2001).","journal-title":"Am. J. Kidney Dis."},{"issue":"20","key":"59552_CR9","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.3390\/jcm11205982","volume":"11","author":"MB Pfeferman","year":"2022","unstructured":"Pfeferman, M. B. et al. Echocardiographic abnormalities in autosomal dominant polycystic kidney disease (ADPKD) patients. J. Clin. Med. 11 (20), 5982 (2022).","journal-title":"J. Clin. Med."},{"key":"59552_CR10","doi-asserted-by":"crossref","unstructured":"Savis, A. et al. Prevalence of cardiac valvar abnormalities in children and young people with autosomal dominant polycystic kidney disease. Pediatr. Nephrol. (2023).","DOI":"10.1007\/s00467-022-05500-w"},{"key":"59552_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh, C. Y. et al. Taiwan\u2019s National health insurance research database: past and future. Clin. Epidemiol. 11, 349\u2013358 (2019).","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"59552_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng, C. L., Kao, Y. H. Y., Lin, S. J., Lee, C. H. & Lai, M. L. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 20 (3), 236\u2013242 (2011).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"59552_CR13","doi-asserted-by":"publisher","first-page":"e2018062","DOI":"10.4178\/epih.e2018062","volume":"40","author":"LY Lin","year":"2018","unstructured":"Lin, L. Y., Warren-Gash, C., Smeeth, L. & Chen, P. C. Data resource profile: the national health insurance research database (NHIRD). Epidemiol. Health. 40, e2018062 (2018).","journal-title":"Epidemiol. Health"},{"key":"59552_CR14","doi-asserted-by":"crossref","unstructured":"Iwagami, M. et al. Introduction to matching in case-control and cohort studies. Glob Health Med (2022).","DOI":"10.37737\/ace.22005"},{"issue":"1","key":"59552_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-017-0325-0","volume":"33","author":"MA Mansournia","year":"2018","unstructured":"Mansournia, M. A., Jewell, N. P. & Greenland, S. Case-control matching: effects, misconceptions, and recommendations. Eur. J. Epidemiol. 33 (1), 5\u201314 (2018).","journal-title":"Eur. J. Epidemiol."},{"issue":"5","key":"59552_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40 (5), 373\u2013383 (1987).","journal-title":"J. Chronic Dis."},{"issue":"12","key":"59552_CR17","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan, V. et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J. Clin. Epidemiol. 57 (12), 1288\u20131294 (2004).","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"59552_CR18","first-page":"188","volume":"12","author":"WP Glasheen","year":"2019","unstructured":"Glasheen, W. P. et al. Charlson Comorbidity Index: ICD-9 update and ICD-10 translation. Am. Health Drug Benefits. 12 (4), 188\u2013197 (2019).","journal-title":"Am. Health Drug Benefits"},{"key":"59552_CR19","unstructured":"Nahhas, R. W. Conditional logistic regression for matched case-control data. In: Introduction to Regression Methods for Public Health Using R. (2026)."},{"issue":"2 Suppl","key":"59552_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2024.07.009","volume":"107","author":"O Devuyst","year":"2025","unstructured":"Devuyst, O. et al. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD). Kidney Int. 107 (2 Suppl), S1\u2013S239 (2025).","journal-title":"Kidney Int."},{"issue":"10174","key":"59552_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall, E., Alam, A. & Perrone, R. D. Autosomal dominant polycystic kidney disease. Lancet 393 (10174), 919\u2013935 (2019).","journal-title":"Lancet"},{"issue":"10","key":"59552_CR22","first-page":"2063","volume":"8","author":"PS Sagar","year":"2023","unstructured":"Sagar, P. S. et al. Cardiovascular manifestations and management in ADPKD. Kidney Int. Rep. 8 (10), 2063\u20132077 (2023).","journal-title":"Kidney Int. Rep."},{"key":"59552_CR23","first-page":"1","volume":"10","author":"N Ebrahimi","year":"2025","unstructured":"Ebrahimi, N., Perrone, R. D. & Chebib, F. T. Cardiovascular complications in ADPKD. Kidney Int. Rep. 10, 1\u201312 (2025).","journal-title":"Kidney Int. Rep."},{"key":"59552_CR24","doi-asserted-by":"publisher","first-page":"109646","DOI":"10.1016\/j.cellsig.2020.109646","volume":"72","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease. Cell. Signal. 72, 109646 (2020).","journal-title":"Cell. Signal."},{"issue":"493","key":"59552_CR25","doi-asserted-by":"publisher","first-page":"eaax0290","DOI":"10.1126\/scitranslmed.aax0290","volume":"11","author":"KA Toomer","year":"2019","unstructured":"Toomer, K. A. et al. Primary cilia defects causing mitral valve to prolapse. Sci. Transl Med. 11 (493), eaax0290 (2019).","journal-title":"Sci. Transl Med."},{"issue":"6","key":"59552_CR26","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/cells11060960","volume":"11","author":"ZE Hale","year":"2022","unstructured":"Hale, Z. E. et al. Primary cilia and their role in acquired heart disease. Cells 11 (6), 960 (2022).","journal-title":"Cells"},{"issue":"5\u20136","key":"59552_CR27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1242\/dmm.003194","volume":"3","author":"S Mangos","year":"2010","unstructured":"Mangos, S. et al. The ADPKD genes pkd1a\/b and pkd2 regulate extracellular matrix formation. Dis. Model. Mech. 3 (5\u20136), 354\u2013365 (2010).","journal-title":"Dis. Model. Mech."},{"issue":"6","key":"59552_CR28","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1046\/j.1523-1755.2000.00446.x","volume":"58","author":"MA Arnaout","year":"2000","unstructured":"Arnaout, M. A. The vasculopathy of autosomal dominant polycystic kidney disease. Kidney Int. 58 (6), 2599\u20132610 (2000).","journal-title":"Kidney Int."},{"issue":"2","key":"59552_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","volume":"17","author":"AB Chapman","year":"2010","unstructured":"Chapman, A. B. Hypertension in autosomal dominant polycystic kidney disease. Adv. Chronic Kidney Dis. 17 (2), 153\u2013163 (2010).","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"24","key":"59552_CR30","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","volume":"371","author":"RW Schrier","year":"2014","unstructured":"Schrier, R. W. et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl. J. Med. 371 (24), 2255\u20132266 (2014).","journal-title":"N Engl. J. Med."},{"issue":"24","key":"59552_CR31","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","volume":"371","author":"VE Torres","year":"2014","unstructured":"Torres, V. E. et al. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl. J. Med. 371 (24), 2267\u20132276 (2014).","journal-title":"N Engl. J. Med."},{"issue":"12","key":"59552_CR32","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1681\/ASN.V5122032","volume":"5","author":"DD Ivy","year":"1995","unstructured":"Ivy, D. D. et al. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 5 (12), 2032\u20132036 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"59552_CR33","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1053\/ajkd.2001.29216","volume":"38","author":"A Lumiaho","year":"2001","unstructured":"Lumiaho, A. et al. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am. J. Kidney Dis. 38 (6), 1208\u20131216 (2001).","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"59552_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00467-022-05500-w","volume":"38","author":"A Savis","year":"2023","unstructured":"Savis, A. et al. Prevalence of cardiac valvar abnormalities in children and young people with autosomal dominant polycystic kidney disease. Pediatr. Nephrol. 38 (3), 705\u2013709 (2023).","journal-title":"Pediatr. Nephrol."},{"issue":"20","key":"59552_CR35","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.3390\/jcm11205982","volume":"11","author":"MB Pfeferman","year":"2022","unstructured":"Pfeferman, M. B. et al. Echocardiographic abnormalities in autosomal dominant polycystic kidney disease (ADPKD). J. Clin. Med. 11 (20), 5982 (2022).","journal-title":"J. Clin. Med."},{"key":"59552_CR36","doi-asserted-by":"publisher","first-page":"31574","DOI":"10.1038\/s41598-024-81536-2","volume":"14","author":"A Koska-\u015aciga\u0142a","year":"2024","unstructured":"Koska-\u015aciga\u0142a, A. et al. Echocardiographic characteristics of autosomal dominant polycystic kidney disease. Sci. Rep. 14, 31574 (2024).","journal-title":"Sci. Rep."},{"key":"59552_CR37","doi-asserted-by":"publisher","first-page":"sfaf279","DOI":"10.1093\/ckj\/sfaf279","volume":"18","author":"G Condello","year":"2025","unstructured":"Condello, G. et al. Cardiac complications in autosomal dominant polycystic kidney disease link to genotype and CKD severity. Clin. Kidney J. 18, sfaf279 (2025).","journal-title":"Clin. Kidney J."},{"key":"59552_CR38","doi-asserted-by":"crossref","unstructured":"Gigante, A. et al. Assessment of cardiovascular disease in autosomal dominant polycystic kidney disease. J Clin. Med 12. (2023).","DOI":"10.3390\/app13127175"},{"key":"59552_CR39","unstructured":"Guarnaroli, M. et al. The impact of autosomal dominant polycystic kidney disease on the heart. J Clin. Med 13. (2024)."},{"issue":"46","key":"59552_CR40","first-page":"3574","volume":"40","author":"TH Marwick","year":"2019","unstructured":"Marwick, T. H. et al. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Eur. Heart J. 40 (46), 3574\u20133585 (2019).","journal-title":"Eur. Heart J."},{"key":"59552_CR41","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.15420\/aer.2021.37","volume":"11","author":"K Kipourou","year":"2022","unstructured":"Kipourou, K., O\u2019Hare, D. & Davenport, A. Valvular heart disease in patients with chronic kidney disease. Arrhythm. Electrophysiol. Rev. 11, e10 (2022).","journal-title":"Arrhythm. Electrophysiol. Rev."},{"issue":"9","key":"59552_CR42","first-page":"1195","volume":"35","author":"J Ternacle","year":"2019","unstructured":"Ternacle, J. et al. Chronic kidney disease and the pathophysiology of valvular heart disease. Can. J. Cardiol. 35 (9), 1195\u20131207 (2019).","journal-title":"Can. J. Cardiol."},{"key":"59552_CR43","doi-asserted-by":"crossref","unstructured":"Hutcheson, J. D., Aikawa, E. & Merryman, W. D. Cardiovascular calcification heterogeneity in chronic kidney disease. Circ Res 132(3). (2023).","DOI":"10.1161\/CIRCRESAHA.123.321760"},{"issue":"10","key":"59552_CR44","doi-asserted-by":"publisher","first-page":"e006044","DOI":"10.1161\/JAHA.117.006044","volume":"6","author":"Z Samad","year":"2017","unstructured":"Samad, Z. et al. Prevalence and outcomes of left-sided valvular heart disease associated with chronic kidney disease. J. Am. Heart Assoc. 6 (10), e006044 (2017).","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"59552_CR45","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/ndt\/gfz133","volume":"35","author":"P Ure\u00f1a-Torres","year":"2020","unstructured":"Ure\u00f1a-Torres, P. et al. Valvular heart disease and calcification in CKD. Nephrol. Dial Transpl. 35 (12), 2046\u20132056 (2020).","journal-title":"Nephrol. Dial Transpl."},{"issue":"11","key":"59552_CR46","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41581-019-0155-2","volume":"15","author":"C Gimpel","year":"2019","unstructured":"Gimpel, C. et al. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat. Rev. Nephrol. 15 (11), 713\u2013726 (2019).","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"59552_CR47","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.4244\/AIJ-D-24-00039","volume":"11","author":"K Dimitriadis","year":"2025","unstructured":"Dimitriadis, K. et al. Mitral annular calcification in interventional cardiology: address all fears. AsiaIntervention 11 (2), e139\u2013e148. https:\/\/doi.org\/10.4244\/AIJ-D-24-00039 (2025).","journal-title":"AsiaIntervention"},{"key":"59552_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40471-014-0027-z","volume":"1","author":"MJ Funk","year":"2014","unstructured":"Funk, M. J. & Landi, S. N. Misclassification in administrative claims data: quantifying the impact on treatment effect estimates. Curr. Epidemiol. Rep. 1, 175\u2013185 (2014).","journal-title":"Curr. Epidemiol. Rep."},{"issue":"10","key":"59552_CR49","doi-asserted-by":"publisher","first-page":"e009162","DOI":"10.1161\/CIRCOUTCOMES.122.009162","volume":"15","author":"JB Strom","year":"2022","unstructured":"Strom, J. B. et al. Characterizing the accuracy of ICD-10 administrative claims for aortic valve disease. Circ. Cardiovasc. Qual. Outcomes. 15 (10), e009162 (2022).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"59552_CR50","doi-asserted-by":"crossref","unstructured":"Cochran, G. L. et al. Research and scholarly methods: mitigating information bias. J Am. Coll. Clin. Pharm 8. (2025).","DOI":"10.1002\/jac5.70054"},{"issue":"3","key":"59552_CR51","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/ije\/dym018","volume":"36","author":"S Sanderson","year":"2007","unstructured":"Sanderson, S., Tatt, I. D. & Higgins, J. P. T. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int. J. Epidemiol. 36 (3), 666\u2013676 (2007).","journal-title":"Int. J. Epidemiol."},{"issue":"19","key":"59552_CR52","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck, M. R., Boon, N. A. & Newby, D. E. Calcific aortic stenosis: a disease of the valve and the myocardium. J. Am. Coll. Cardiol. 60 (19), 1854\u20131863. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.093 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9981","key":"59552_CR53","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","volume":"385","author":"ACM Ong","year":"2015","unstructured":"Ong, A. C. M. & Harris, P. C. Autosomal dominant polycystic kidney disease. Lancet 385 (9981), 1993\u20132002 (2015).","journal-title":"Lancet"},{"issue":"20","key":"59552_CR54","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa031644","volume":"350","author":"GA Block","year":"2004","unstructured":"Block, G. A. et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. N. Engl. J. Med. 350 (20), 1296\u20131305. https:\/\/doi.org\/10.1056\/NEJMoa031644 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"59552_CR55","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1161\/01.CIR.0000030939.45740.43","volume":"106","author":"P Raggi","year":"2002","unstructured":"Raggi, P. et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? Circulation 106 (15), 1860\u20131865. https:\/\/doi.org\/10.1161\/01.CIR.0000030939.45740.43 (2002).","journal-title":"Circulation"},{"issue":"Suppl 1","key":"59552_CR56","doi-asserted-by":"publisher","first-page":"i27","DOI":"10.1093\/ckj\/sfae421","volume":"18","author":"L H\u00e9naut","year":"2025","unstructured":"H\u00e9naut, L. et al. Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies. Clin. Kidney J. 18 (Suppl 1), i27\u2013i45. https:\/\/doi.org\/10.1093\/ckj\/sfae421 (2025).","journal-title":"Clin. Kidney J."},{"key":"59552_CR57","doi-asserted-by":"crossref","unstructured":"Sterrantino, A. F. et al. Observational studies: practical tips for avoiding common biases. Lancet Healthy Longev 5. (2024).","DOI":"10.1016\/j.lansea.2024.100415"},{"key":"59552_CR58","first-page":"2407","volume":"9","author":"SD Emerson","year":"2024","unstructured":"Emerson, S. D. et al. Secondary use of routinely collected administrative health data: considerations for observational research. Int. J. Popul. Data Sci. 9, 2407 (2024).","journal-title":"Int. J. Popul. Data Sci."},{"key":"59552_CR59","doi-asserted-by":"crossref","unstructured":"Ricotta, E. E. et al. Observational research in epidemic settings: a roadmap to better evidence. Lancet Reg. Health (2025).","DOI":"10.1136\/bmjgh-2024-017981"},{"key":"59552_CR60","unstructured":"Rajaram, R., Barnard, C. & Bilimoria, K. Y. Does surveillance bias influence the validity of measures used to compare hospitals? J Patient Saf 13(1). (2017)."},{"issue":"3","key":"59552_CR61","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/aje\/kwy250","volume":"188","author":"TJ VanderWeele","year":"2019","unstructured":"VanderWeele, T. J. & Mathur, M. B. Is the Bonferroni correction really so bad? Am. J. Epidemiol. 188 (3), 617\u2013618 (2019).","journal-title":"Am. J. Epidemiol."},{"key":"59552_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12874-019-0754-4","volume":"19","author":"V Vickerstaff","year":"2019","unstructured":"Vickerstaff, V., Omar, R. Z. & Ambler, G. Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes. BMC Med. Res. Methodol. 19, 129 (2019).","journal-title":"BMC Med. Res. Methodol."},{"key":"59552_CR63","first-page":"111644","volume":"177","author":"R Hooper","year":"2025","unstructured":"Hooper, R. To adjust, or not to adjust, for multiple comparisons. J. Clin. Epidemiol. 177, 111644 (2025).","journal-title":"J. Clin. Epidemiol."},{"key":"59552_CR64","unstructured":"Vahanian, A. et al. 2025 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 46. (2025)."},{"issue":"4S","key":"59552_CR65","first-page":"S1","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105 (4S), S1\u2013S150 (2024).","journal-title":"Kidney Int."},{"key":"59552_CR66","unstructured":"Borghol, A. H., Elhassan, E. A. & Ong, A. C. M. Autosomal dominant polycystic kidney disease: An overview of clinical features and management. Kidney Med (2025)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59552-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:04:31Z","timestamp":1790859871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59552-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59552"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59552-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the Code of Ethics of the World Medical Association (Declaration of Helsinki). The Institutional Review Board of the Tri-Service General Hospital approved this study (TSGHIRB: No. E202616016) and waived the need for individual consent since all the identification data were encrypted in the NHIRD.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30408"}}